Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pharmaceutical Medicine|February 4, 2021
The Qualitative Value of Facilitated Regulatory Pathways in Europe, USA, and Japan: Benefits, Barriers to Utilization, and Suggested SolutionsMagdalena Bujar, Neil McAuslane, Lawrence LibertiFrontiers in Pharmacology|February 8, 2019
The Reliability and Relevance of a Quality of Decision Making Instrument, Quality of Decision-Making Orientation Scheme (QoDoS), for Use During the Lifecycle of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.International Journal of Health Policy and Management|July 3, 2020
A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of MedicinesMagdalena Bujar, Neil McAuslane, Stuart Walker, et al.Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.Frontiers in Pharmacology|April 27, 2017
Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment: A Systematic Review of the LiteratureMagdalena Bujar, Neil McAuslane, Stuart R Walker, et al.Therapeutic Innovation & Regulatory Science|May 31, 2020
Quality Decision-Making Practices in Pharmaceutical Companies and Regulatory Authorities: Current and Proposed Approaches to Its DocumentationMagdalena Bujar, Neil McAuslane, Patricia Connelly, et al.Therapeutic Innovation & Regulatory Science|February 20, 2020
Quality Decision Making in Health Technology Assessment: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Stuart R Walker, et al.Therapeutic Innovation & Regulatory Science|September 21, 2018
Assessing the Quality of Decision Making in the Development and Regulatory Review of Medicines: Identifying Biases and Best PracticesMagdalena Bujar, Ronan Donelan, Neil McAuslane, et al.Pageof 1